Medicines Transparency Kyrgyzstan

1,434 views

Published on

Presentation on medicines transparency in Kyrgyzstan at the launch of the Medicines Transparency Alliance (MeTA) in London, May 2008

Published in: Health & Medicine, Technology
1 Comment
0 Likes
Statistics
Notes
  • After you got all the information on Fioricet, another point on your agenda should be the price for it. http://www.fioricetsupply.com resolves this problem. Now you can make the decision to buy.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Views
Total views
1,434
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
9
Comments
1
Likes
0
Embeds 0
No embeds

No notes for slide
  • Title of presentation 04/06/09 MeTA
  • Medicines Transparency Kyrgyzstan

    1. 1. MeTA in Kyrgyzstan MeTA in Kyrgyzstan Mariam Djankorozova, MeTA Co-Director 16/05/2008
    2. 2. Agenda <ul><li>Medicines Issues and Priorities in Kyrgyzstan </li></ul><ul><li>Past and Current Experience in Addressing Medicines Issues </li></ul><ul><li>Future Plans to Address Medicines Issues through MeTA </li></ul><ul><li>Intended outcomes </li></ul>16/05/2008
    3. 3. Overview: Medicines Issues and Priorities <ul><li>Limited access to medicines </li></ul><ul><ul><li>Limited affordability and availability </li></ul></ul><ul><ul><ul><li>Especially important for chronic diseases highly prevalent in KG </li></ul></ul></ul><ul><ul><ul><li>Major problem in rural areas (70% population lives in rural areas) </li></ul></ul></ul><ul><ul><ul><ul><li>1 pharmacy:1500 people urban; 1 pharmacy:4500 people rural </li></ul></ul></ul></ul><ul><li>Low Quality of Medicines </li></ul><ul><ul><li>Counterfeit medicines from abroad; unable to fight against smuggled medicines </li></ul></ul><ul><li>Limited access to reliable & timely information on medicines </li></ul><ul><ul><li>Drug info. system under-developed, no info. on price, quality </li></ul></ul>06/04/09
    4. 4. Limited access to medicines <ul><li>Case of Hypertension </li></ul><ul><ul><li>Several important and less expensive medicines (HCTZ) are not prescribed by doctors or recommended by pharmacists in favour of medicines that are highly promoted (enalapril) </li></ul></ul><ul><ul><ul><li>Written prescription differs from oral directions given by doctor </li></ul></ul></ul><ul><ul><ul><li>People cannot afford expensive medicines; Insurance system insufficiently funded to adequately cover all beneficiaries </li></ul></ul></ul><ul><ul><ul><li>Preference for branded generics that are much more expensive </li></ul></ul></ul><ul><ul><ul><li>No mechanism to control promotion </li></ul></ul></ul><ul><ul><li>MeTA offers a mechanism to provide information to counteract promotion; engage CSOs to reach public with information </li></ul></ul>06/04/09
    5. 5. Low Quality of Medicines <ul><li>Medicines entering country through official channels </li></ul><ul><ul><li>80 medicines per year are withdrawn due to poor quality </li></ul></ul><ul><ul><li>Currently no link between DRA and customs </li></ul></ul><ul><li>Medicines entering country through informal channels </li></ul><ul><ul><li>Major problem; mountainous country difficult to monitor; </li></ul></ul><ul><ul><li>Impossible to differentiate counterfeit from legitimate medicines </li></ul></ul><ul><ul><li>Sold to pharmacies at low prices; </li></ul></ul><ul><ul><li>Some are substandard (lower amount of active ingredient, some have no active ingredient) </li></ul></ul><ul><li>MeTA offers opportunity to collect information and link activities between customs and DRA; disseminate information on quality of medicines in official and informal channels to consumers; CSOs can assist DRA to monitor and educate </li></ul>06/04/09
    6. 6. Limited access to reliable & timely information on medicines <ul><li>Need information on: </li></ul><ul><ul><li>Import, legislation, licensing, certification, registration, quality, price, procurement </li></ul></ul><ul><li>MeTA can provide a mechanism for creating a single space on internet where all information can be accessible to all population (consumers and professionals); mobile phones may be an alternative to internet in rural areas; price monitoring will be key </li></ul><ul><ul><li>Must be two-way communication with feedback from population, utilizing CSOs for outreach </li></ul></ul>06/04/09
    7. 7. Summary <ul><li>Kyrgyzstan has been a leader in the region in addressing pharmaceutical issues </li></ul><ul><ul><li>One of the first countries to implement national drug policy, essential medicines list, standardized national treatment guidelines with training </li></ul></ul><ul><ul><li>Insurance system for medicines, projects to create networks of pharmacies in rural areas </li></ul></ul><ul><li>Still, more work is needed; Ultimate goal is to improve access to medicines, especially for the poor </li></ul><ul><li>MeTA offers opportunity for government, private sector and civil society to work together and disclose information on medicines towards goals of increasing access to medicines </li></ul>06/04/09
    8. 8. Where to Get More Information <ul><li>Department of Drug Provision and Medical Equipment </li></ul><ul><ul><li>www.pharm.med.kg </li></ul></ul><ul><li>Health Insurance Fund </li></ul><ul><ul><li>www.foms.med.kg </li></ul></ul><ul><li>Kyrgyz Republic National Health Care Reform Program </li></ul><ul><ul><li>www.manastaalimi.med.kg/eng/ </li></ul></ul>06/04/09
    9. 9. Thank you! <ul><li>Name of presenter: Mariam Djankorozova </li></ul><ul><li>Email: m_djankorozova@foms.med.kg </li></ul><ul><li>Mobile number: + 996 555 929412 </li></ul><ul><li>International Secretariat, info@metasecretariat.org </li></ul><ul><li>MeTA: www.MedicinesTransparency.org </li></ul><ul><li>DFID: www.dfid.gov.uk </li></ul>06/04/09
    10. 10. Kyrgyzstan

    ×